Skip to main content
SpringerLink
Log in

ASO Author Reflections: Individualized Mediastinal Lymph Node Dissection for Lung Cancer: Do Not Neglect Station 3A Lymph Node

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Asamura H, Chansky K, Crowley J, et al. The International Association for the Study of Lung Cancer Lung Cancer staging project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer. J Thorac Oncol. 2015; 10(12):1675–84.

    Article  CAS  Google Scholar 

  2. Zheng H, Gao W, Fei K, et al. Prognostic role of station 3A mediastinal nodes for non-small-cell lung cancers. Interact Cardiovasc Thorac Surg. 2013;17(3):447–54.

    Article  Google Scholar 

  3. Naruke T, Tsuchiya R, Kondo H, et al. Lymph node sampling in lung cancer: how should it be done? Eur J Cardiothorac Surg. 1999;16 Suppl 1:S17–24.

    Article  Google Scholar 

  4. Liu C, Wei S, Guo C, et al. Clinical significance of station 3A lymph node dissection in patients with right-side non-small-cell lung cancer: a retrospective propensity-matched analysis. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08786-y.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Zhao K, Wei S, Mei J, et al. Survival benefit of left lower paratracheal (4L) lymph node dissection for patients with left-sided non-small cell lung cancer: once neglected but of great importance. Ann Surg Oncol. 2019;26(7):2044–52.

    Article  Google Scholar 

Download references

Author information

Author notes

  1. Chengwu Liu and Shiyou Wei have contributed equally to this work.

Authors and Affiliations

  1. Department of Thoracic Surgery, West China Hospital, Chengdu, Sichuan, China

    Chengwu Liu MD, Shiyou Wei MD & Lunxu Liu MD, PhD, FRCS

  2. Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Sichuan University, Chengdu, China

    Chengwu Liu MD, Shiyou Wei MD & Lunxu Liu MD, PhD, FRCS

Authors
  1. Chengwu Liu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shiyou Wei MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lunxu Liu MD, PhD, FRCS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lunxu Liu MD, PhD, FRCS.

Ethics declarations

Disclosure

The authors have no conflicts of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, C., Wei, S. & Liu, L. ASO Author Reflections: Individualized Mediastinal Lymph Node Dissection for Lung Cancer: Do Not Neglect Station 3A Lymph Node. Ann Surg Oncol 27 (Suppl 3), 846–847 (2020). https://doi.org/10.1245/s10434-020-08876-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-08876-x

Search

Navigation